MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 5, 2014, Pages 945-954

  Mirza, Ahmed A ^a   Kahle, Michael P ^a   Ameka, Magdalene ^a   Campbell, Edward M ^a   Cuevas, Bruce D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Fibronectin; Focal adhesion; Kinase; MEKK2

Indexed keywords

FIBRONECTIN; FOCAL ADHESION; KINASE; MEKK2;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FIBRONECTINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; GENE SILENCING; HUMANS; MAP KINASE KINASE KINASES; NEOPLASM INVASIVENESS; PHOSPHORYLATION;

EID: 84894435068     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.01.029     Document Type: Article

References (26)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Petrie R.J., Doyle A.D., Yamada K.M. Random versus directionally persistent cell migration. Nat. Rev. Mol. Cell Biol. 2009, 10:538-549.
3. Huttenlocher A., Horwitz A.R. Integrins in cell migration. Cold Spring Harb. Perspect. Biol. 2011, 3:a005074.
4. Humphries J.D., Byron A., Humphries M.J. Integrin ligands at a glance. J. Cell Sci. 2006, 119:3901-3903.
5. Zaidel-Bar R., Geiger B. The switchable integrin adhesome. J. Cell Sci. 2010, 123:1385-1388.
6. Zaidel-Bar R., Itzkovitz S., Ma'ayan A., Iyengar R., Geiger B. Functional atlas of the integrin adhesome. Nat. Cell Biol. 2007, 9:858-867.
7. Liu S., Calderwood D.A., Ginsberg M.H. Integrin cytoplasmic domain-binding proteins. J. Cell Sci. 2000, 113(Pt 20):3563-3571.
8. Cronan M.R., Nakamura K., Johnson N.L., Granger D.A., Cuevas B.D., Wang J.G., Mackman N., Scott J.E., Dohlman H.G., Johnson G.L. Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis. Oncogene 2012, 31:3889-3900.
9. Cuevas B.D., Abell A.N., Johnson G.L. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007, 26:3159-3171.
10. Kennedy N.J., Davis R.J. Role of JNK in tumor development. Cell Cycle 2003, 2:199-201.
11. Ventura J.J., Hubner A., Zhang C., Flavell R.A., Shokat K.M., Davis R.J. Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell 2006, 21:701-710.
12. Huang C., Jacobson K., Schaller M.D. MAP kinases and cell migration. J. Cell Sci. 2004, 117:4619-4628.
13. Garrington T.P., Ishizuka T., Papst P.J., Chayama K., Webb S., Yujiri T., Sun W., Sather S., Russell D.M., Gibson S.B., Keller G., Gelfand E.W., Johnson G.L. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO J. 2000, 19:5387-5395.
14. Witowsky J.A., Johnson G.L. Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways. J. Biol. Chem. 2003, 278:1403-1406.
15. Yan L., Carr J., Ashby P.R., Murry-Tait V., Thompson C., Arthur J.S. Knockout of ERK5 causes multiple defects in placental and embryonic development. BMC Dev. Biol. 2003, 3:11.
16. Regan C.P., Li W., Boucher D.M., Spatz S., Su M.S., Kuida K. Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9248-9253.
17. Sawhney R.S., Liu W., Brattain M.G. A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling. J. Cell. Physiol. 2009, 219:152-161.
18. Nakamura K., Johnson G.L. PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. J. Biol. Chem. 2003, 278:36989-36992.
19. Cronan M.R., Nakamura K., Johnson N.L., Granger D.A., Cuevas B.D., Wang J.G., Mackman N., Scott J.E., Dohlman H.G., Johnson G.L. Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis. Oncogene 2012, 31:3889-3900.
20. Lyle K.S., Raaijmakers J.H., Bruinsma W., Bos J.L., de Rooij J. cAMP-induced Epac-Rap activation inhibits epithelial cell migration by modulating focal adhesion and leading edge dynamics. Cell. Signal. 2008, 20:1104-1116.
21. Jaerve A., Schiwy N., Schmitz C., Mueller H.W. Differential effect of aging on axon sprouting and regenerative growth in spinal cord injury. Exp. Neurol. 2011, 231:284-294.
22. Cuevas B.D., Abell A.N., Witowsky J.A., Yujiri T., Johnson N.L., Kesavan K., Ware M., Jones P.L., Weed S.A., DeBiasi R.L., Oka Y., Tyler K.L., Johnson G.L. MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J. 2003, 22:3346-3355.
23. Webb K., Hlady V., Tresco P.A. Relationships among cell attachment, spreading, cytoskeletal organization, and migration rate for anchorage-dependent cells on model surfaces. J. Biomed. Mater. Res. 2000, 49:362-368.
24. Dhanasekaran D.N., Kashef K., Lee C.M., Xu H., Reddy E.P. Scaffold proteins of MAP-kinase modules. Oncogene 2007, 26:3185-3202.
25. Matitau A.E., Gabor T.V., Gill R.M., Scheid M.P. MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase. J. Biol. Chem. 2013, 288:28293-28302.
26. Yamashita M., Ying S., Zhang G., Li C., Cheng S., Deng C., Zhang Y. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 2005, 121:101-113.